Form 8-K - Current report:
SEC Accession No. 0001493152-25-009452
Filing Date
2025-03-07
Accepted
2025-03-06 20:49:19
Documents
16
Period of Report
2025-03-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49448
2 ex99-1.htm EX-99.1 21977
3 ex99-1_001.jpg GRAPHIC 51611
  Complete submission text file 0001493152-25-009452.txt   368980

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE biaf-20250306.xsd EX-101.SCH 3769
5 XBRL DEFINITION FILE biaf-20250306_def.xml EX-101.DEF 26602
6 XBRL LABEL FILE biaf-20250306_lab.xml EX-101.LAB 36624
7 XBRL PRESENTATION FILE biaf-20250306_pre.xml EX-101.PRE 25226
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5806
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 25717313
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)